Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128,390 | 113,713 | 168,543 | 139,653 | 97,249 |
| Marketable Securities | 438,974 | 462,404 | 401,922 | 434,707 | 321,664 |
| Receivables | 121 | 583 | N/A | N/A | 165,000 |
| Other current assets | 0 | 0 | 23,363 | 22,825 | 0 |
| TOTAL | $577,574 | $586,424 | $602,526 | $605,860 | $591,641 |
| Non-Current Assets | |||||
| PPE Net | 3,860 | 4,100 | 4,108 | 3,530 | 3,190 |
| Investments And Advances | 78,638 | 102,703 | 102,493 | 123,517 | 140,252 |
| Other Non-Current Assets | 8,116 | 8,461 | 8,879 | 9,225 | 9,642 |
| TOTAL | $90,614 | $115,264 | $115,480 | $136,272 | $153,084 |
| Total Assets | $668,188 | $701,688 | $718,006 | $742,132 | $744,725 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,339 | 5,646 | 3,249 | 2,917 | 1,615 |
| Accrued Expenses | 28,269 | 22,868 | 15,397 | 11,843 | 23,693 |
| TOTAL | $45,441 | $44,942 | $35,507 | $35,112 | $47,398 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9,550 | 14,200 | 14,688 | 16,895 | 18,891 |
| Other Non-Current Liabilities | 8,040 | 8,521 | 9,106 | 9,792 | 10,356 |
| TOTAL | $8,040 | $11,309 | $14,481 | $17,968 | $22,032 |
| Total Liabilities | $53,481 | $56,251 | $49,988 | $53,080 | $69,430 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,809 | 62,516 | 62,211 | 61,982 | 61,384 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -470,671 | -426,287 | -386,948 | -352,177 | -340,522 |
| Other shareholders' equity | 641 | 525 | -15 | 85 | -82 |
| TOTAL | $614,707 | $645,437 | $668,018 | $689,052 | $675,295 |
| Total Liabilities And Equity | $668,188 | $701,688 | $718,006 | $742,132 | $744,725 |